Companies: 10,795·Total market cap: $144.5T

Knight Therapeutics Inc.

Knight Therapeutics Inc.

KHTRFOTCHealthcare● Active

$6.48

+$0.37(+6.06%)

Market Cap$635264856

P/E Ratio—

52W High$6.54

52W Low$4.073

Avg Volume4K

Open$6.54

Beta0.07

股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Knight Therapeutics Inc.（KHTRF）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KHTRF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$0.05Earnings history

PE Ratio (TTM)126.8×PE Ratio deep dive

Revenue (TTM)$510.9MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding99.6MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Knight Therapeutics Inc. 数据

分析师预测$— · Buy

股息不分红

营收$449.7M+21.12%

盈利EPS $-0.05-220.85%

市盈率126.8×

财务快照

FY 2025Revenue$449.7M▲ +21.12% YoY

202320242025

FY 2025Net Income-$5.4M▼ 223.95% YoY

202320242025

FY 2025EPS$-0.05▼ 220.85% YoY

202320242025

TTM:Revenue: $510.9MNet Income: $5.4MEPS: $0.05View income statement →

分析师评级与目标价

Buy1 位分析师

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$—Low

$6.48Current

$—Avg Target

$—High

合计: 1 · 买入占比: 100.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Knight Therapeutics Inc.

$6.48+6.06%$635.3M #2

Allergy Therapeutics plc

$0.13+0.00%$655.5M #3

Avacta Group Plc

$1.00+0.00%$437.4M #4

BioInvent International AB (publ)

$6.63+101.61%$436.3M #5

COLTENE Holding AG

$76.25+24.67%$455.6M #6

Cresco Labs Inc.

$0.95+5.03%$336.4M

股票表现

1D+6.06%

1W+7.11%

1M+2.53%

3M+50.00%

YTD+48.97%

1Y+46.94%

5Y+49.31%

关于 Knight Therapeutics Inc.

CEOSamira Sakhia

IPO DateApr 3, 2014

Employees745

CountryCA

Websitegud-knight.com

Knight Therapeutics Inc. operates as a specialized pharmaceutical enterprise, actively engaged in the development, acquisition, in-licensing, out-licensing, marketing, and distribution of a broad spec…

Drug Manufacturers - Specialty & Generic HealthcareOTCCA

关于股票概览与关键数据

Knight Therapeutics Inc.（KHTRF）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Apr 3, 2014 在 OTC 上市。截至最近交易日，KHTRF 股价为 $6.48，市值约为 $635.3M。过去12个月累计回报 +46.94%，年初至今回报 +48.97%。

根据 1 位华尔街分析师，Knight Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Knight Therapeutics Inc. 营收 $449.7M，净利润 -$5.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Knight Therapeutics Inc.（KHTRF）股价为 $6.48，在 OTC 上市，52周区间为 $4.07 – $6.54。

KHTRF 最新股价KHTRF quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议